Drug Index

Emapalumab

 
print

Mechanism :

Human monoclonal antibody that targets and inhibits interferon-gamma (IFN-gamma).


Indication :

• Hemophagocytic Lymphohistiocytosis (Currently in phase III trial)


Contraindications :

Not known.


Dosing :

1 mg/kg IV infusion along with dexamethasone once every 3 days for the first 2 weeks, then twice weekly.


Adverse Effect :

Not known.


Interaction :

Not yet specified.


07/15/2019 05:58:15 Emapalumab
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0